Flinton Capital Management’s Emergent Biosolutions EBS Stock Holding History

Flinton Capital Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$215K	Buy	4,112 +320	+8%	+$14.9K	0.01%	654
2019 Q2	$183K	Buy	3,792 +48	+1%	+$2.3K	0.01%	696
2019 Q1	$189K	Hold	3,744	–	–	0.01%	683
2018 Q4	$222K	Buy	3,744 +16	+0.4%	+$1.03K	0.01%	628
2018 Q3	$245K	Buy	3,728 +16	+0.4%	+$934	0.01%	668
2018 Q2	$187K	Hold	3,712	–	–	0.01%	673
2018 Q1	$195K	Buy	3,712 +464	+14%	+$23.1K	0.01%	657
2017 Q4	$151K	Buy	3,248 +560	+21%	+$23.6K	0.01%	707
2017 Q3	$109K	Buy	2,688 +752	+39%	+$27.2K	﹤0.01%	726
2017 Q2	$66K	Buy	1,936 +976	+102%	+$30.1K	﹤0.01%	773
2017 Q1	$28K	Sell	960 -928	-49%	-$28.2K	﹤0.01%	804
2016 Q4	$62K	Buy	+1,888	New	+$56.6K	﹤0.01%	684

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Flinton Capital Management's EBS Position: Q3 2019 in Review

Flinton Capital Management increased its Emergent Biosolutions (EBS) stake by 8.4% in Q3 2019, buying an estimated $14.9K and bringing the position to 4,112 shares worth $215K. The position accounts for 0.01% of the portfolio, ranked #654.

Flinton Capital Management first reported a position in EBS in Q4 2016 and has held it in 12 quarters since. The position peaked at $245K in Q3 2018. 244 funds tracked by Wall St. Rank hold EBS as of Q3 2019.

Flinton Capital Management held 4,112 shares of Emergent Biosolutions worth $215K as of Q3 2019.
Flinton Capital Management bought 320 Emergent Biosolutions shares in Q3 2019, an estimated $14.9K.
Emergent Biosolutions made up 0.01% of Flinton Capital Management's portfolio in Q3 2019, its #654 holding.
Flinton Capital Management first reported a position in Emergent Biosolutions in Q4 2016 and has held it in 12 quarters since.
Flinton Capital Management's Emergent Biosolutions position peaked at $245K in Q3 2018.
244 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.